US Patent Issued to SUN PHARMACEUTICAL INDUSTRIES on June 10 for "Process for preparing enantiomerically enriched JAK inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,707, issued on June 10, was assigned to SUN PHARMACEUTICAL INDUSTRIES INC. (Princeton, N.J.).

"Process for preparing enantiomerically enriched JAK inhibitors" was invented by Robert S. Lewis (Lexington, Mass.), Mahender Reddy Karla (Lexington, Mass.), Kathryn E. Kavouris (Cambridge, Mass.), Yong Dong (Chestnut Hill, Mass.), Adam J. Morgan (Ashland, Mass.) and Cameron J. Cowden (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Improved processes and intermediates for preparing ruxolitinib and deuterated analogs of ruxolitinib are disclosed."

The patent was filed on Feb. 6, 2020, under Application No. 17/428,850.

*For further informat...